论文部分内容阅读
目的:比较胺碘酮与利多卡因对急性心肌梗死(AMI)患者室性心律失常的临床疗效。方法:选取2013年10月—2015年10月间诊治的急性心肌梗死(AMI)后室性心律失常患者80例,采用随机列表法将其分为观察组和对照组,每组40例;对照组患者均给予利多卡因治疗,观察组患者则给予胺碘酮治疗;比较两组患者治疗7 d后的总有效率和不良反应的发生率。结果:观察组患者治疗后的总有效率为95.00%显著高于对照组为80.00%(P<0.05),不良反应的发生率为15.00%低于对照组为32.50%(P<0.05)。结论:对AMI患者室性心律失常采用胺碘酮治疗的临床疗效优于利多卡因,且安全性较高。
Objective: To compare the clinical effects of amiodarone and lidocaine on ventricular arrhythmias in patients with acute myocardial infarction (AMI). Methods: Eighty patients with ventricular arrhythmia after diagnosis and treatment of acute myocardial infarction (AMI) between October 2013 and October 2015 were selected and randomly divided into observation group and control group with 40 cases in each group. Patients in the two groups were treated with lidocaine, while patients in the observation group were treated with amiodarone. The total effective rate and the incidence of adverse reactions were compared between the two groups after 7 days of treatment. Results: The total effective rate of observation group was 95.00%, significantly higher than that of control group (80.00%, P <0.05). The incidence of adverse reactions was 15.00%, which was significantly lower than that of control group (32.50%, P <0.05). Conclusion: The clinical efficacy of amiodarone in AMI patients is superior to lidocaine in the treatment of ventricular arrhythmias, and its safety is high.